Renal artery stent revascularization with embolic protection in patients with ischemic nephropathy

Kidney International

Volumn 70, Issue 5, 2006, Pages 948-955

  Holden, A ^a   Hill, A ^a   Jaff, M R ^b   Pilmore, H ^a  

^a AUCKLAND CITY HOSPITAL   (New Zealand)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Atheromatous embolization; Ischemic nephropathy; Renal artery stenosis

Indexed keywords

ADULT; AGED; ARTERY EMBOLISM; ARTICLE; ATHEROMATOSIS; ATHEROSCLEROSIS; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEASIBILITY STUDY; FEMALE; HIGH RISK PATIENT; HUMAN; ISCHEMIC NEPHROPATHY; KIDNEY ARTERY STENOSIS; KIDNEY DYSFUNCTION; KIDNEY FUNCTION TEST; KIDNEY ISCHEMIA; MAJOR CLINICAL STUDY; MALE; NONSURGICAL INVASIVE THERAPY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RENAL ARTERY ATHEROSCLEROSIS; RENAL ARTERY STENT REVASCULARIZATION; RENAL STENTING; THERAPY EFFECT;

AGED; AGED, 80 AND OVER; ANGIOPLASTY, BALLOON; BALLOON DILATATION; CREATININE; DISEASE PROGRESSION; EMBOLISM; FEMALE; FILTRATION; HUMANS; ISCHEMIA; KIDNEY; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTHESES AND IMPLANTS; REGIONAL BLOOD FLOW; RENAL ARTERY OBSTRUCTION; STENTS; TREATMENT OUTCOME;

EID: 33747843331     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5001671     Document Type: Article

References (61)

1. Missouris CG, Buckenham T, Cappucio FP, MacGregor GA. Renal artery stenosis: a common and important problem in patients with peripheral vascular disease. Am J Med 1994; 96: 10-14.
2. Mailloux LU, Napolitano B, Bellucci AG et al. Renal vascular disease causing end-stage renal disease, incidence, clinical correlates, and outcomes: a 20 year experience. Am J Kidney Dis 1994; 24: 622-629.
3. Hansen KJ. Prevalence of ischaemic nephropathy in the atherosclerotic population. Am J Kidney Dis 1994; 24: 615-621.
4. Zierler RE, Bergelin RO, Isaacson JA, Strandness DE. Natural history of atherosclerotic renal artery stenosis: a prospective study with duplex ultrasonography. J Vasc Surg 1994; 19: 250-258.
5. Strandness Jr DE. Natural history of renal artery stenosis. Am J Kidney Dis 1994; 24: 630-635.
6. Palmaz JC. The current status of vascular intervention in ischaemic nephropathy. JVIR 1998; 9: 539-543.
7. Zeller T, Frank U, Muller C et al. Stent supported angioplasty of severe atherosclerotic renal artery stenosis preserves renal function and improves blood pressure control. J Endovasc Ther 2004; 11: 95-106.
8. Leertouwer TC, Gussenhoven EJ, Bosch JL et al. Stent placement for renal artery stenosis: where do we stand? A meta-analysis. Radiology 2000; 216: 78-85.
9. Harden PN, MacLeod MJ, Rodger RSC et al. Effect of renal artery stenting on progression of renovascular renal failure. Lancet 1997; 349: 1133-1136.
10. Dorros G, Jaff M, Mathiak L et al. Four year follow-up of Palmaz-Schatz stent revascularization as treatment for atherosclerotic renal artery stenosis. Circulation 1998; 98: 642-647.
11. Kuan Y, Hossain M, Surman J et al. GFR prediction using the MDRD and Cockcroft and Gault equations in patients with end-stage renal disease. Nephrol Dial Transplant 2005; 20: 2394-2401.
12. Sharafuddin MJ, Raboi CA, Abu-Yousef M et al. Renal artery stenosis: duplex US after angioplasty and stent placement. Radiology 2001; 220: 168-173.
13. Uzu T, Takeji M, Yamada N et al. Prevalence and outcome of renal artery stenosis in atherosclerotic patients with renal dysfunction. Hypertens Res 2002; 25: 537-542.
14. Rihal CS, Textor SC, Breen JF et al. Incidental renal artery stenosis among a prospective cohort of hypertensive patients undergoing coronary angiography. Mayo Clin Proc 2002; 77: 309-316.
15. Caps MT, Perissinotto C, Zierler RE et al. Prospective study of atherosclerotic disease progression in the renal artery. Circulation 1998; 98: 2866-2872.
16. Dean RH, Tribble RW, Hansen KJ et al. Evolution of renal insufficiency in ischaemic nephropathy. Ann Surg 1991; 213: 446-455.
17. Meyrier A. Renal vascular lesions in the elderly: nephrosclerosis or atheromatous renal disease? Nephrol Dial Transplant 1996; 11(Suppl 9): 45-52.
18. Marone LK, Clouse WD, Dorer DJ et al. Preservation of renal function with surgical revascularization in patients with atherosclerotic renovascular disease. J Vasc Surg 2004; 39: 322-329.
19. Nordmann AJ, Woo K, Parkes R, Logan AG. Balloon angioplasty or medical therapy for hypertensive patients with atherosclerotic renal artery stenosis? A meta-analysis of randomised controlled trials. Am J Med 2003; 114: 44-50.
20. Watson P, Madjipetrou P, Cox SV et al. Effects of renal artery stenting on renal function and size in patients with atherosclerotic renovascular disease. Circulation 2000; 102: 1671-1677.
21. Van de Ven PJ, Kaatee R, Beutler JJ et al. Arterial stenting and balloon angioplasty in ostial atherosclerotic renovascular disease: a randomised trial. Lancet 1999; 353: 282-286.
22. Blum U, Krumme B, Flugel P et al. Treatment of ostial renal artery stenoses with vascular endoprostheses after unsuccessful angioplasty. N Engl J Med 1997; 336: 459-465.
23. Giroux MF, Soulez G, Therasse E et al. Percutaneous revascularization of the renal arteries: predictors of outcome. JVIR 2000; 11: 713-720.
24. Zeller T, Frank U, Muller C et al. Predictors of improved renal function after percutaneous stent-supported angioplasty of severe atherosclerotic ostial renal artery stenosis. Circulation 2003; 10: 1006-1014.
25. Gognet F, Gracier JM, Dranssart M et al. Percutaneous transluminal renal angioplasty in atheroma with renal failure: long term outcomes in 99 patients. Eur Radiol 2001; 11: 2524-2530.
26. Murray S, Martin M, Amoedo ML et al. Rapid decline in renal function reflects reversibility and predicts outcome after angioplasty in renal artery stenosis. Am J Kidney Dis 2002; 39: 60-66.
27. Sivamurthy N, Surowiec SM, Culakova E et al. Divergent outcomes after percutaneous therapy for symptomatic renal artery stenosis. J Vasc Surg 2004; 39: 565-574.
28. Gaines PA, Cumberland DC, Kennedy A et al. Cholesterol embolisation: a lethal complication of vascular catheterisation. Lancet 1988; 1: 168-170.
29. Scolari F, Tardanico R, Zani R et al. Cholesterol crystal embolism: a recognizable cause of renal disease. Am J Kidney Dis 2000; 36: 1089-1109.
30. Scolari F, Ravani P, Pola A et al. Predictors of renal and patient outcomes in atheroembolic renal disease: a prospective study. J Am Soc Nephrol 2003; 14: 1584-1590.
31. Ohki T, Marin ML, Lyon RT et al. Ex vivo human carotid artery bifurcation stenting: correlation of lesion characteristics with embolic potential. J Vasc Surg 1998; 27: 463-471.
32. Baim DS, Wahr D, George B et al. Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts. Circulation 2002; 105: 1285-1290.
33. Orlandi G, Fanucchi S, Fioretti C et al. Characteristics of cerebral microembolism during carotid stenting and angioplasty alone. Arch Neurol 2001; 58: 1410-1413.
34. Hiramoto J, Hansen K, Pan XM et al. Atheroemboli during renal angioplasty: an ex vivo study. J Vasc Surg 2005; 41: 1026-1030.
35. Li SS, Wang CH, Lam CW. Renal angioplasty under protection of the PercuSurge Guardwire Plus system. J Invasive Cardiol 2003; 15: 148-150.
36. Eggebrecht H, Dirsh O, Haude M et al. A new temporary occlusion and aspiration system for prevention of distal embolization during percutaneous transluminal renal angioplasty. J Interv Cardiol 2000; 113: 339-342.
37. Henry M, Henry I, Polydorou A et al. Renal angioplasty and stenting: long-term results and the potential of protection devices. Expert Rev Cardiovasc Ther 2005; 3: 321-334.
38. Holden A, Hill A. Renal angioplasty and stenting with distal protection of the main renal artery in ischemic nephropathy: early experience. J Vasc Surg 2003; 38: 962-968.
39. Zeller T, Frank U, Muller C et al. Technological advances in the design of catheters and devices used in renal artery interventions: impact on complications. J Endovasc Ther 2003; 10: 1006-1014.
40. Sienko J, Wisniewska M, Ostrowski M et al. Factors that impact on immediate graft function in patients after renal transplantation. Transplant Proc 2003; 35: 2153-2154.
41. Haas CA, Dinchman KH, Nasrallah PF, Spirnak JP. Traumatic renal artery occlusion: a 15-year review. J Trauma-Injury Infect Crit Care 1998; 5: 557-561.
42. Safi HJ, Miller III CC, Huynh TT et al. Distal aortic perfusion and cerebrospinal fluid drainage for thoracoabdominal and descending thoracic aortic repair: ten years of organ protection. Ann Surg 2003; 238: 372-380.
43. Rapp JH, Pan XM, Sharp FR et al. Atheroemboli to the brain: size threshold for causing acute neuronal cell death. J Vasc Surg 2000; 32: 68-76.
44. Sharafuddin MJ, Stolpen AH, Dixon BS et al. Value of MR angiography before percutaneous transluminal renal artery angioplasty and stent placement. JVIR 2002; 13: 901-908.
45. Nolan BW, Schermerhorn ML, Rowell E et al. Outcomes of renal artery angioplasty and stenting using low-profile systems. J Vasc Surg 2005; 41: 46-52.
46. Solomon R, Werner C, Mann D et al. Effects of saline, mannitol and furosemide on acute decrease in renal function induced by radiocontrast agents. N Engl J Med 1994; 331: 1416-1420.
47. Tepel M, van der Giet M, Schwarzfeld C et al. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 2000; 343: 180-184.
48. Rashid ST, Salman M, Myint F et al. Prevention of contrast-induced nephropathy in vascular patients undergoing angiography: a randomized controlled trial of intravenous N-acetylcysteine. J Vasc Surg 2005; 40: 1136-1141.
49. Zeller T, Muller C, Frank U et al. Gadodiamide as an alternative contrast agent during angioplasty in patients with contraindications to iodinated media. J Endovasc Ther 2002; 9: 625-632.
50. Harb TS, Laird JR, Dieter RS et al. Renal artery stenting using gadodiamide arteriography in patients with baseline renal insufficiency. J Endovasc Ther 2004; 11: 553-559.
51. Eschelman DJ, Sullivan KL, Bonn J, Gardiner GA. Carbon dioxide as a contrast agent to guide vascular interventional procedures. AJR 1998; 171: 1265-1270.
52. Baboolal K, Evans C, Moore RH. Incidence of end-stage renal disease in medically treated patients with severe bilateral atherosclerotic renovascular disease. Am J Kidney Dis 1998; 31: 971-977.
53. Wright JR, Shurrab AE, Cheung C et al. A prospective study of the determinants of renal functional outcome and mortality in atherosclerotic renovascular disease. Am J Kidney Dis 2002; 39: 1153-1161.
54. Buecker A, Spuentrup E, Ruebben A, Gunther RW. Artifact free in-stent lumen visualization by standard magnetic resonance angiography using a new metallic magnetic resonance imaging stent. Circulation 2002; 105: 1772-1775.
55. Vignali C, Bargellini I, Lazzereschi M et al. Predictive factors of in-stent restenosis in renal artery stenting: a retrospective analysis. Cardiovasc Intervent Radiol 2005; 28: 296-302.
56. Kereiakes DJ, Cox DA, Hermiller JB et al. Guidant Multi-Link Vision Registry Investigators. Usefulness of a chromium coronary stent alloy. Am J Cardiol 2003; 92: 463-466.
57. Akbulut M, Ozbay Y, Karaca I et al. The effect of long-term clopidogrel use on neointimal formation after percutaneous coronary intervention. Coronary Artery Dis 2004; 115: 347-352.
58. Scarpioni R, Michieletti E, Cristinelli L et al. Atherosclerotic renovascular disease: medical therapy versus medical therapy plus renal artery stenting in preventing renal failure progression: the rationale and study design of a prospective, multicenter and randomised trial (NITER). J Nephrol 2005; 18: 423-428.
59. Murphy TP, Cooper CJ, Dworkin LD et al. The cardiovascular outcomes with renal atherosclerotic lesions (CORAL) Study: rationale and methods. JVIR 2005; 16: 1295-1300.
60. National Kidney Foundation. K-DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Kidney Disease Outcome Quality Initiative. Am J Kidney Dis 2002; 39(2 Suppl 1): S1-S246.
61. Zellar T, Frank U, Muller C et al. Duplex ultrasound for follow-up examination after stent-angioplasty of ostial renal artery stenoses. Ultraschall Med 2002; 23: 315-319.